Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
Recruiting · NCT05989347 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy | Neoplasms by Site, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, glucose metabolism disease, hyperinsulinism, metabolic disease, neoplasm, skin disorder | Recruiting | Phase 1 | 2026-05-22 | NCT05989347 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yale University | 458 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Yale Cancer Center Smilow Cancer Hospital | New Haven | United States | 1 |